Washington Trust Advisors’s Guardant Health GH Stock Holding History

Washington Trust Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-107	Closed	-$6.68K	–	624
2025 Q3	$6.68K	Buy	+107	New	+$5.82K	﹤0.01%	584
2024 Q1	–	Sell	-178	Closed	-$4.82K	–	665
2023 Q4	$4.82K	Hold	178	–	–	﹤0.01%	575
2023 Q3	$5.28K	Hold	178	–	–	﹤0.01%	545
2023 Q2	$6.37K	Sell	178 -131	-42%	-$3.76K	﹤0.01%	515
2023 Q1	$7.24K	Hold	309	–	–	﹤0.01%	548
2022 Q4	$8.4K	Sell	309 -859	-74%	-$39.3K	﹤0.01%	524
2022 Q3	$63K	Buy	1,168 +56	+5%	+$2.88K	0.01%	351
2022 Q2	$45K	Buy	1,112 +33	+3%	+$1.64K	﹤0.01%	416
2022 Q1	$71K	Sell	1,079 -125	-10%	-$8.55K	0.01%	394
2021 Q4	$120K	Buy	+1,204	New	+$125K	0.01%	331

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Washington Trust Advisors's GH Position: Q4 2025 in Review

Washington Trust Advisors sold out of Guardant Health (GH) in Q4 2025, closing a stake of 107 shares — an estimated $6.68K sold.

Washington Trust Advisors first reported a position in GH in Q4 2021 and held it in 10 quarters. The position peaked at $120K in Q4 2021. 497 funds tracked by Wall St. Rank hold GH as of Q4 2025.

Washington Trust Advisors reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
Washington Trust Advisors sold 107 Guardant Health shares in Q4 2025, an estimated $6.68K.
Washington Trust Advisors first reported a position in Guardant Health in Q4 2021 and held it in 10 quarters.
Washington Trust Advisors's Guardant Health position peaked at $120K in Q4 2021.
497 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on Washington Trust Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.